These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37822407)

  • 61. Antibiotic-resistant acne: lessons from Europe.
    Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Systematic review of Propionibacterium acnes resistance to systemic antibiotics.
    Cooper AJ
    Med J Aust; 1998 Sep; 169(5):259-61. PubMed ID: 9762064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
    Han R; Blencke HM; Cheng H; Li C
    Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterisation of Cutibacterium acnes phylotypes in acne and in vivo exploratory evaluation of Myrtacine
    Pécastaings S; Roques C; Nocera T; Peraud C; Mengeaud V; Khammari A; Dréno B
    J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():15-23. PubMed ID: 29894577
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N; Nakaminami H; Noguchi N; Kurokawa I; Nishijima S; Sasatsu M
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
    Fluhr JW; Gloor M; Dietz P; Höffler U
    Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bacterial resistance in French acne patients.
    Dumont-Wallon G; Moyse D; Blouin E; Dréno B
    Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibiotic resistance in acne: changes, consequences and concerns.
    Karadag AS; Aslan Kayıran M; Wu CY; Chen W; Parish LC
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):73-78. PubMed ID: 32474948
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
    Leyden JJ; Wortzman M; Baldwin EK
    Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.
    Nair SS; Zolotarskaya OY; Beckwith MJ; Ohman DE; Wynne KJ
    Macromol Biosci; 2017 Sep; 17(9):. PubMed ID: 28605136
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cross-sectional Pilot Study of Antibiotic Resistance in Propionibacterium Acnes Strains in Indian Acne Patients Using 16S-RNA Polymerase Chain Reaction: A Comparison Among Treatment Modalities Including Antibiotics, Benzoyl Peroxide, and Isotretinoin.
    Sardana K; Gupta T; Kumar B; Gautam HK; Garg VK
    Indian J Dermatol; 2016; 61(1):45-52. PubMed ID: 26955094
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Systemic antibiotic therapy of acne vulgaris].
    Ochsendorf F
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S31-46. PubMed ID: 20482690
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Topical acne treatments in Europe and the issue of antimicrobial resistance.
    Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
    Taylor GA; Shalita AR
    Am J Clin Dermatol; 2004; 5(4):261-5. PubMed ID: 15301572
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Non-antibiotic Isotretinoin Treatment Differentially Controls
    Ryan-Kewley AE; Williams DR; Hepburn N; Dixon RA
    Front Microbiol; 2017; 8():1381. PubMed ID: 28790988
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current issues in antimicrobial therapy for the treatment of acne.
    Leyden JJ
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():51-5. PubMed ID: 11843235
    [TBL] [Abstract][Full Text] [Related]  

  • 79. BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.
    Alexis A; Del Rosso JQ; Desai SR; Downie JB; Draelos ZD; Feser C; Forconi R; Fowler JF; Gold M; Kaufman-Janette J; Lain E; Lee M; Ling M; Shamban AT; Werschler WP; Daniels A
    J Clin Aesthet Dermatol; 2018 Nov; 11(11):25-35. PubMed ID: 30588271
    [No Abstract]   [Full Text] [Related]  

  • 80. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
    Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
    Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.